Abdullah Esmail

869 total citations
61 papers, 425 citations indexed

About

Abdullah Esmail is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Abdullah Esmail has authored 61 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 27 papers in Surgery and 19 papers in Cancer Research. Recurrent topics in Abdullah Esmail's work include Cancer Genomics and Diagnostics (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). Abdullah Esmail is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). Abdullah Esmail collaborates with scholars based in United States, Jordan and Saudi Arabia. Abdullah Esmail's co-authors include Maen Abdelrahim, Ashish Saharia, Rafik M. Ghobrial, Ala Abudayyeh, Sudha Kodali, David W. Victor, Robert McMillan, Kirk Heyne, Naoka Murakami and Jenny C. Chang and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Frontiers in Pharmacology.

In The Last Decade

Abdullah Esmail

55 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdullah Esmail United States 13 219 192 149 92 92 61 425
Masahiro Shinoda Japan 12 162 0.7× 167 0.9× 87 0.6× 45 0.5× 72 0.8× 45 359
Erin Maynard United States 12 192 0.9× 269 1.4× 241 1.6× 81 0.9× 76 0.8× 41 553
Jiayin Yang China 15 121 0.6× 196 1.0× 340 2.3× 95 1.0× 53 0.6× 28 443
Wusheng Lu China 12 96 0.4× 100 0.5× 220 1.5× 88 1.0× 61 0.7× 30 338
Jin Sub Choi South Korea 15 203 0.9× 334 1.7× 319 2.1× 60 0.7× 198 2.2× 22 540
Hiroaki Nagano Japan 11 106 0.5× 133 0.7× 188 1.3× 33 0.4× 41 0.4× 41 374
Hirofumi Kanemura Japan 14 127 0.6× 234 1.2× 207 1.4× 78 0.8× 53 0.6× 24 533
Jesse Civan United States 10 211 1.0× 47 0.2× 79 0.5× 94 1.0× 63 0.7× 35 423
Che-Chuan Loong Taiwan 10 89 0.4× 217 1.1× 450 3.0× 113 1.2× 71 0.8× 14 614
Priyanka Pathak United States 8 206 0.9× 155 0.8× 187 1.3× 25 0.3× 96 1.0× 23 425

Countries citing papers authored by Abdullah Esmail

Since Specialization
Citations

This map shows the geographic impact of Abdullah Esmail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Esmail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Esmail more than expected).

Fields of papers citing papers by Abdullah Esmail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Esmail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Esmail. The network helps show where Abdullah Esmail may publish in the future.

Co-authorship network of co-authors of Abdullah Esmail

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Esmail. A scholar is included among the top collaborators of Abdullah Esmail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Esmail. Abdullah Esmail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aljuhani, Ateyatallah, et al.. (2025). Minimally Invasive Approach Versus Traditional Approach for Treating Congenital Diaphragmatic Hernia: A Systematic Review and Meta-Analysis. Cureus. 17(1). e77596–e77596. 2 indexed citations
2.
Abdelrahim, Maen, Abdullah Esmail, Richard D. Kim, et al.. (2025). Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study. Cancers. 17(11). 1814–1814.
3.
Esmail, Abdullah, et al.. (2025). Evaluating Standardization of Neoadjuvant Immunotherapy in Transplant-Eligible Hepatocellular Carcinoma Populations. Jordan Medical Journal. 1 indexed citations
4.
Abdelrahim, Maen & Abdullah Esmail. (2025). The use of durvalumab and tremelimumab after atezolizumab and bevacizumab in patients with hepatocellular carcinoma: case report and literature review. Immunotherapy. 17(11). 783–790. 1 indexed citations
5.
Abdelrahim, Maen, Abdullah Esmail, Richard D. Kim, et al.. (2025). Real-world (RW) experience with atezolizumab + bevacizumab (A+B) for the treatment of unresectable HCC (uHCC): A multicenter study.. Journal of Clinical Oncology. 43(4_suppl). 537–537. 2 indexed citations
6.
Esmail, Abdullah, et al.. (2024). The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Journal of Clinical Medicine. 13(17). 4994–4994.
7.
Abdelrahim, Maen, Abdullah Esmail, Aiwu Ruth He, et al.. (2024). Circulating tumor DNA monitoring for recurrence detection and treatment response assessment in HCC. HPB. 26. S605–S605. 1 indexed citations
8.
Abdelrahim, Maen, Abdullah Esmail, Taizo Hibi, & Vincenzo Mazzaferro. (2024). Focal Update on Immunotherapy and Liver Transplantation in the Era of Transplant Oncology. Current Oncology. 31(9). 5021–5026. 1 indexed citations
9.
Esmail, Abdullah, et al.. (2024). Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments. Frontiers in Oncology. 14. 1386699–1386699. 15 indexed citations
10.
Esmail, Abdullah, Ala Abudayyeh, Naoka Murakami, et al.. (2023). Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology. Cancers. 15(5). 1433–1433. 12 indexed citations
11.
Abdelrahim, Maen, Abdullah Esmail, Aiwu Ruth He, et al.. (2023). 960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC). Annals of Oncology. 34. S600–S600. 2 indexed citations
12.
13.
Abdelrahim, Maen, Abdullah Esmail, Ala Abudayyeh, et al.. (2022). Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series. Current Oncology. 29(5). 3585–3594. 15 indexed citations
14.
Esmail, Abdullah, Sudha Kodali, Edward A. Graviss, et al.. (2022). P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma. Annals of Oncology. 33. S308–S308. 3 indexed citations
15.
Abdelrahim, Maen, et al.. (2022). Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge. Frontiers in Pharmacology. 13. 848676–848676. 12 indexed citations
16.
Abdelrahim, Maen, Abdullah Esmail, Ashish Saharia, et al.. (2022). Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience. Frontiers in Oncology. 12. 908687–908687. 13 indexed citations
17.
Abdelrahim, Maen, Abdullah Esmail, Ashish Saharia, et al.. (2022). P-165 The feasibility of tumor recurrence detection in liver post-transplantation for patients with hepatocellular carcinoma via personalized, tumor-informed ctDNA testing. Annals of Oncology. 33. S308–S309. 4 indexed citations
18.
19.
Esmail, Abdullah, et al.. (2020). Frequency of gallbladder stones among patients underwent abdominal ultrasound in a tertiary hospital in Sana’a City, Yemen. Malaysian Journal of Medicine and Health Sciences. 16(107). 2 indexed citations
20.
Esmail, Abdullah, et al.. (2020). Evaluation of primary internal limiting membrane peeling in cases with rhegmatogenous retinal detachment. International Journal of Retina and Vitreous. 6(1). 8–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Shinoda Breakdown of academic impact, for papers by Erin Maynard Breakdown of academic impact, for papers by Jiayin Yang Breakdown of academic impact, for papers by Wusheng Lu Breakdown of academic impact, for papers by Jin Sub Choi Breakdown of academic impact, for papers by Hiroaki Nagano Breakdown of academic impact, for papers by Hirofumi Kanemura Breakdown of academic impact, for papers by Jesse Civan Breakdown of academic impact, for papers by Che-Chuan Loong Breakdown of academic impact, for papers by Priyanka Pathak
Rankless by CCL
2026